Crossmark

Can platelet to neutrophil ratio (PNR) serve as a viable alternative tool for monitoring sickle cell disease patients on hydroxyurea in low income countries?

Crossref DOI link: https://doi.org/10.1007/s00277-025-06598-2

Published Online: 2025-12-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chibuife, Efobi Chilota

Chisom Adaobi, Nri-Ezedi

Odini, Franklin

Deepika, Habib Darbari

Habib, Nana-Bilkisu

Andrew, Campbell
License Information

Text and Data Mining valid from 2025-12-10

Version of Record valid from 2025-12-10
More Information

Article History

Received: 1 June 2025

Accepted: 22 August 2025

First Online: 10 December 2025

Declarations

:

: Ethical approval for the study was obtained from the institutional review board (IRB) at Children's National Hospital, Washington DC, United States of America.. IRB number: Pro00010744

: As this was a retrospective chart review using de-identified data, individual patient consent was waived by the IRB in accordance with ethical regulations and the principles outlined in the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below